🇺🇸 FDA
Patent

US 11725039

α/β t-cell receptor and methods of using it

granted A61KA61K38/00A61K38/17

Quick answer

US patent 11725039 (α/β t-cell receptor and methods of using it) held by University College Cardiff Consultants Limited expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
University College Cardiff Consultants Limited
Grant date
Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/00, A61K38/17, A61K40/11, A61K40/32